Entera Bio (ENTX) Payables (2017 - 2026)
Entera Bio's Payables was $575,000 in Q2 2026, up 50.1% from $383,000 a year earlier and up 109.9% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Payables at Entera Bio came in at $448,000, up 239.4% from FY2024.
- Payables has now increased for three consecutive years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- In earlier years, Payables was $132,000 in FY2024 (+59.0%), $83,000 in FY2023 (+388.2%), $17,000 in FY2022 (-89.8%) and $166,000 in FY2021 (+1.2%).
- The Q2 2026 figure marks the highest quarterly Payables since Q2 2021.
- Compared with a year earlier, Payables has increased for seven straight quarters, with growth averaging 120.1% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q2 2025 (growth of 455.1%); the worst was Q2 2022 (a decline of 92.6%).
- Per Business Quant data, ENTX's Payables in the three quarters before Q2 2026 was $274,000 (Q1 2026), $448,000 (Q4 2025) and $216,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Entera Bio | 132.59 Mn | 101.46 Mn | - | 575,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 575,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 216,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 413,000.00 |
| Jun 30, 2022 | 109,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Jun 30, 2021 | 1.47 Mn |
API Access
Entera Bio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();